04:34pm AI Agents Test the Limits of Human Control MT
04:23pm KeyBanc Initiates Jack Henry & Associates at Overweight With $190 Price Target MT
04:21pm Benchmark Upgrades CEVA to Buy From Hold, Price Target is $42 MT
04:08pm Seaport Global Downgrades Energy Recovery to Neutral From Buy MT
04:06pm MORNING BID AMERICAS-Go slow AI RE
04:06pm UBS Initiates UMB Financial at Neutral With $155 Price Target MT
04:05pm AI companies must prove services are safe for citizens, EU Commission says RE
04:04pm Microsoft-Backed OpenAI Agents Linked to Cyberattack on Coding Platform RubyGems MT
04:00pm Anthropic CEO Urges AI Industry to Slow Development Pace; Chip Stocks Slide MT
03:32pm 'The Pitt' and 'Hacks' compete for gold at TV's Emmy Awards  RE
03:27pm Why AI leaders are suddenly talking about slowing down RE
03:22pm Google, OpenAI and Anthropic Leaders Discussing Establishment of AI Standards Body MT
03:19pm Goldman Sachs Adjusts Price Target on Adobe to $200 From $190, Keeps Sell Rating MT
03:18pm China Urges Open, Ethical Development After Calls for AI Slowdown MT
02:55pm Phillip Securities Adjusts Price Target on Apple to $300 From $290, Keeps Reduce Rating MT
02:46pm Tesla to Launch Long-Delayed Electric Sports Car Roadster on Oct. 1 MT
02:46pm Tesla Regains US EV Market Share as Rivals Pull Back MT
02:28pm Cellectis to Transform Into In Vivo Gene Editing Company MT
02:16pm Tesla Establishes Subsidiary in Vietnam MT
02:15pm AstraZeneca Breast Cancer Combination Treatment Misses Main Target in Late-Stage Study MT
02:03pm Oil Jumps, Nasdaq Futures Slide as AI-Related Stocks Tumble Worldwide DJ
01:58pm Qualcomm Inc/de Insider Sold Shares Worth $457,129, According to a Recent SEC Filing MT
01:56pm Meta Platforms Insider Sold Shares Worth $13,005,575, According to a Recent SEC Filing MT
01:15pm Viasat, Space42 Agree to Form Equatys With Up to $1 Billion Equity Commitment MT
01:14pm Tesla Makes Formal Foray Into Vietnam; Establishes Local Subsidiary MT
01:11pm Astrazeneca Says Cancer Drugs Enhertu, Tagrisso Show Survival Benefits in Late-Stage Trials MT
12:12pm Encouraging phase 1 data for Nanobiotix's JNJ-1900 Zonebourse
12:08pm Viasat, Space42 commit up to $1 billion to direct-to-device venture RE
11:41am Tesla sets up Vietnam unit, registration filing shows RE
11:31am ASML extends chipmaking dominance as customers embrace High NA RE
11:19am AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial DJ
10:26am UK Stocks-Factors to watch on September 14 RE
10:25am Nordic stocks in North America, Ericsson rose 1.8% FW
09:22am AstraZeneca Says Lung Cancer Drug Tagrisso Sustains Overall Survival Benefit MT
09:02am Shares drop in Asia as oil rises, rate hikes loom RE
08:54am AstraZeneca's Phase 3 Trial of Combination Treatment for Breast Cancer Fails to Meet Primary Endpoint MT
08:18am AstraZeneca, Daiichi report Enhertu benefit in advanced lung cancer AN
06:15am 'Musk' director wants viewers to reclaim power from 'tech oligarchs' RE
05:02am Anthropic CEO Urges AI Slowdown, Backed by OpenAI, Musk; Trump Downplays Risks MT
13/09 Anthropic CEO Proposes Three-step Plan to Pace Global AI Development MT
No results match your criteria
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!